23 May 2013
Keywords: priority, review, novartis, exjade, swiss, drug, giant
Article | 27 June 2005
Swiss drug giant Novartis says that the US Food and Drug Administration has accepted its New Drug Application for Exjade ( ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
27 June 2005
22 May 2013
© 2013 thepharmaletter.com